Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

NK cells mediate clearance of CD8+ T cell-resistant tumors in response to STING agonists.

Nicolai CJ, Wolf N, Chang IC, Kirn G, Marcus A, Ndubaku CO, McWhirter SM, Raulet DH.

Sci Immunol. 2020 Mar 20;5(45). pii: eaaz2738. doi: 10.1126/sciimmunol.aaz2738.

PMID:
32198222
2.

Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade.

Hsu J, Hodgins JJ, Marathe M, Nicolai CJ, Bourgeois-Daigneault MC, Trevino TN, Azimi CS, Scheer AK, Randolph HE, Thompson TW, Zhang L, Iannello A, Mathur N, Jardine KE, Kirn GA, Bell JC, McBurney MW, Raulet DH, Ardolino M.

J Clin Invest. 2018 Oct 1;128(10):4654-4668. doi: 10.1172/JCI99317. Epub 2018 Sep 10.

Supplemental Content

Support Center